Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NNMT | P40261 | 3/20 | 0.64 |
| ▸ | DOT1L | Q8TEK3 | 6/20 | 0.62 |
| ▸ | EHMT2 | Q96KQ7 | 4/20 | 0.62 |
| ▸ | NSD2 | O96028 | 3/20 | 0.62 |
| ▸ | SETD7 | Q8WTS6 | 3/20 | 0.62 |
| ▸ | CARM1 | Q86X55 | 3/20 | 0.62 |
| ▸ | PCMT1 | P22061 | 2/20 | 0.62 |
| ▸ | TRDMT1 | O14717 | 2/20 | 0.62 |
| ▸ | PRMT5 | O14744 | 2/20 | 0.62 |
| ▸ | INMT | O95050 | 2/20 | 0.62 |
| ▸ | METTL3 | Q86U44 | 2/20 | 0.62 |
| ▸ | PRMT1 | Q99873 | 2/20 | 0.62 |
| ▸ | EHMT1 | Q9H9B1 | 2/20 | 0.62 |
| ▸ | METTL14 | Q9HCE5 | 2/20 | 0.62 |
| ▸ | RNMT | O43148 | 1/20 | 0.62 |
| ▸ | TPMT | P51580 | 1/20 | 0.62 |
| ▸ | NSD1 | Q96L73 | 1/20 | 0.62 |
| ▸ | SETD2 | Q9BYW2 | 1/20 | 0.62 |
| ▸ | NSD3 | Q9BZ95 | 1/20 | 0.62 |
| ▸ | FASN | P49327 | 3/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29378634 | 1.00 | NNMT (0.64) | NNMTDOT1LEHMT2NSD2SETD7 | |
| SCHEMBL27514667 | 1.00 | NNMT (0.64) | NNMTDOT1LEHMT2NSD2SETD7 | |
| SCHEMBL22444816 | 1.00 | NNMT (0.64) | NNMTDOT1LEHMT2NSD2SETD7 | |
| Hydrogen Sulfide SCHEMBL27973834 | 0.99 | NNMT (0.62) | NNMTDOT1LEHMT2NSD2SETD7 | |
| Adenosine SCHEMBL27687165 | 0.96 | DOT1L (0.68) | NNMTDOT1LEHMT2NSD2SETD7 | |
| SCHEMBL29802656 | 0.94 | EGFR (0.63) | NNMTDOT1LEHMT2NSD2SETD7 | |
| SCHEMBL29620377 | 0.93 | NNMT (0.57) | NNMTDOT1LEHMT2NSD2SETD7 | |
| SCHEMBL21853808 | 0.93 | NNMT (0.57) | NNMTDOT1LEHMT2NSD2SETD7 | |
| SCHEMBL16057650 | 0.93 | NNMT (0.57) | NNMTDOT1LEHMT2NSD2SETD7 | |
| SCHEMBL3636881 | 0.92 | DOT1L (0.64) | NNMTDOT1LEHMT2NSD2SETD7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1040 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025055194-A1 | GENETICALLY ENGINEERED BACTERIUM FOR DE NOVO SYNTHESIS OF VANILLIN USING GLUCOSE AS SUBSTRATE, AND USE THEREOF | 北京化工大学 | 2025-03-20 | — | — | WO | claimed |
| CN-119291173-B | Application of marker and diagnostic method for neuropsychiatric magnetic particle chemiluminescence kit for lupus | 四川携光生物技术有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-119291173-A | Application of marker and diagnostic method for neuropsychiatric magnetic particle chemiluminescence kit for lupus | 四川携光生物技术有限公司 | 2025-01-10 | — | — | CN | claimed |
| WO-2024102452-A1 | HEPATOPROTECTIVE PROBIOTIC COMPOSITIONS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-05-16 | — | — | WO | claimed |
| EP-4359560-A1 | MULTIRESIDUAL METHOD FOR DETECTING AND/OR QUANTIFYING AMINO ACIDS, ORGANIC ACIDS AND/OR MODIFIED NUCLEOTIDES BY MEANS OF HILIC CHROMATOGRAPHIC SEPARATION AND MS/MS | Crescendo Care S.r.l. (IT) | 2024-05-01 | — | — | EP | claimed |
| WO-2024081156-A1 | DETECTION OF NUCLEIC ACID AND NON-NUCLEIC ACID TARGET MOLECULES | VEDABIO, INC. (US) | 2024-04-18 | — | — | WO | claimed |
| EP-4304573-A1 | TREATMENT OF CORONAVIRUS INFECTIONS USING SAM CYCLE INHIBITORS | Technische Universität München (DE) | 2024-01-17 | — | — | EP | claimed |
| CN-117004544-B | Genetically engineered bacterium for synthesizing vanillin from head by taking glucose as substrate and application thereof | 北京化工大学 | 2023-12-12 | — | — | CN | claimed |
| CN-117004544-A | Genetically engineered bacterium for synthesizing vanillin from head by taking glucose as substrate and application thereof | 北京化工大学 | 2023-11-07 | — | — | CN | claimed |
| EP-4225924-A1 | UNIVERSAL RIBOSWITCH FOR INDUCIBLE GENE EXPRESSION | Wageningen Universiteit (NL) | 2023-08-16 | — | — | EP | claimed |
| WO-2003078574-A2 | NOVEL METABOLIC TARGETS AND MARKERS | LIPOMICS TECHNOLOGIES, INC. (US) | 2003-09-25 | — | — | WO | claimed |
| CN-1416472-A | Preparation and high expression of recombinant S-adenosylhomocysteinase (SAHH) with high specific activity and improved analysis of S-adenosylmethionine (SAM) | ANTICANCER INC (US) | 2003-05-07 | — | — | CN | claimed |
| EP-1301212-A1 | PHARMACEUTICALLY ACTIVE COMPOUND | Norgine Europe BV (NL) | 2003-04-16 | — | — | EP | claimed |
| EP-1282415-A2 | COMPOUNDS AND METHODS FOR REGULATING BACTERIAL GROWTH AND PATHOGENESIS | Princeton University Office of Techology Licensing & I.P. (US) | 2003-02-12 | — | — | EP | claimed |
| WO-2003002588-A1 | CHEMICAL SYNTHESIS OF S-ADENOSYL-L-METHIONINE WITH ENRICHMENT OF (S,S)-ISOMER | ORCHID CHEMICALS & PHARMACEUTICALS LIMITED (IN) | 2003-01-09 | — | — | WO | claimed |
| WO-2002007771-A1 | PHARMACEUTICALLY ACTIVE COMPOUND | NORGINE EUROPE BV (NL) | 2002-01-31 | — | — | WO | claimed |
| WO-2001085664-A2 | COMPOUNDS AND METHODS FOR REGULATING BACTERIAL GROWTH AND PATHOGENESIS | PRINCETON UNIVERSITY (US) | 2001-11-15 | — | — | WO | claimed |
| EP-1135144-A1 | COMPOSITIONS AND METHODS FOR REGULATING BACTERIAL PATHOGENESIS | Princeton University (US) | 2001-09-26 | — | — | EP | claimed |
| CN-1275060-A | Liver function test | NORGINE LTD (GB) | 2000-11-29 | — | — | CN | claimed |
| WO-2000032152-A2 | COMPOSITIONS AND METHODS FOR REGULATING BACTERIAL PATHOGENESIS | PRINCETON UNIVERSITY (US) | 2000-06-08 | — | — | WO | claimed |